Heather Catt

2PUBLICATIONS
3CO-AUTHORS
Nanotoxicology, health and safetyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 03, 2019
Value Assessment and Quantitative Benefit-Risk Modelling of Biosimilar Infliximab for Crohn's Disease.

Heather Catt, Keith Bodger, Jamie J Kirkham

|Mar 05, 2019
Systematic review: outcomes and adverse events from randomised trials in Crohn's disease.

Heather Catt, Dyfrig Hughes, Jamie J Kirkham

Pageof 1